当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析

翰宇药业

(300199)

  

流通市值:211.18亿  总市值:250.13亿
流通股本:7.46亿   总股本:8.83亿

翰宇药业(300199)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.45亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益74124.26万元,未分配利润-170489.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产337204.94万元,负债263080.68万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入549,442,106.79309,969,965.34590,199,011.64375,225,390.5
营业总成本407,008,743.17231,507,233.07708,040,579.18459,578,775.38
其他经营收益
营业利润160,040,053.3376,444,987.52-161,386,422.37-26,228,246.69
利润总额159,960,853.0776,345,940.73-162,412,259.29-27,593,945.61
净利润144,519,356.9269,439,025.34-180,091,957.93-35,828,756.23
每股收益
其他综合收益-323,282.97-99,383.361,864,588.58-713,914.14
综合收益总额144,196,073.9569,339,641.98-178,227,369.35-36,542,670.37
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计799,663,777.91494,618,808.48463,048,006.84548,032,020.7
非流动资产:
非流动资产合计2,572,385,649.182,543,426,762.222,545,177,633.252,569,086,743.84
资产总计3,372,049,427.093,038,045,570.73,008,225,640.093,117,118,764.54
流动负债:
流动负债合计1,666,206,256.721,591,998,857.861,424,553,168.651,285,645,119
非流动负债:
非流动负债合计964,600,584.4779,660,558.84986,625,959.421,101,058,449.87
负债合计2,630,806,841.122,371,659,416.72,411,179,128.072,386,703,568.87
所有者权益(或股东权益):
归属于母公司股东权益合计723,772,170.75648,395,821.48578,626,837.31706,930,696.43
股东权益合计741,242,585.97666,386,154597,046,512.02730,415,195.67
负债和股东权益合计3,372,049,427.093,038,045,570.73,008,225,640.093,117,118,764.54
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计520,801,293.43202,910,272.01766,211,441.71501,843,341.73
经营活动现金流出小计363,656,725.13162,484,976.69601,505,781.16413,773,728.7
经营活动产生的现金流量净额157,144,568.340,425,295.32164,705,660.5588,069,613.03
投资活动产生的现金流量:
投资活动现金流入小计4,028,964.83,746,209.951,646,205.2546,140,700.24
投资活动现金流出小计77,668,234.2134,282,205.58121,655,382.874,866,778.32
投资活动产生的现金流量净额-73,639,269.41-30,535,995.68-70,009,177.55-28,726,078.08
筹资活动产生的现金流量:
筹资活动现金流入小计753,157,32070,000,0001,531,683,185.231,241,333,185.23
筹资活动现金流出小计561,139,756.53120,077,959.581,877,160,686.721,507,182,727.29
筹资活动产生的现金流量净额192,017,563.47-50,077,959.58-345,477,501.49-265,849,542.06
汇率变动对现金及现金等价物的影响1,822,042.821,595,530.553,377,635.211,998,721.31
现金及现金等价物净增加额277,344,905.18-38,593,129.39-247,403,383.28-204,507,285.8
期末现金及现金等价物余额369,877,748.3453,939,713.7792,532,843.16135,428,940.64
补充资料:
现金及现金等价物的净增加额277,344,905.18--247,403,383.28-
TOP↑